Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 28, 2023

Chinese guideline on the primary prevention of cardiovascular diseases in primary health care.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

To promote the implementation of cardiovascular disease primary prevention recommendations in primary health care settings and shift the focus from disease treatment to people's health.

Design

Clinical guideline

Discussion

Loading...

Member takes

Overview

Guides grassroots CVD primary prevention in China; extends 2020 national guideline with practical recommendations for clinicians.

Structured PICO

P
Population
Individuals targeted for primary prevention of cardiovascular diseases in primary health care settings in China
I
Intervention
Cardiovascular disease primary prevention measures including risk assessment, lifestyle intervention, blood pressure management, lipid management, type 2 diabetes management, and aspirin use

This document provides practical, Q&A-based recommendations to facilitate the implementation of cardiovascular disease primary prevention guidelines in Chinese primary health care settings.

Cite This Study

A 2023 study studied this question. The Chinese primary care guideline for cardiovascular disease prevention provides recommendations on risk assessment, lifestyle, blood pressure, lipid, and diabetes management, and aspirin use.

synapsesocial.com/papers/6a610fe47bdfcb316faabb36https://doi.org/10.3760/cma.j.cn112148-20230106-00014
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1[Chinese guideline on the primary prevention of cardiovascular diseases].2020 · 77 citations
  2. 2Chinese Guideline on the Primary Prevention of Cardiovascular Diseases2021 · 47 citations
  3. 3Chinese Guideline on the Primary Prevention of Cardiovascular Diseases: Time to Start Better Cardiovascular Primary Prevention2021 · 8 citations
  4. 4[Guideline on the assessment and management of cardiovascular risk in China].2019 · 71 citations
  5. 5[National guideline for hypertension management in China (2019)].2020 · 56 citations